Clinical Trial to Determine the Efficacy and Safety of Insulin Eye Drops in Dry Eye in Patients with Topical Hypotensors

Who May Qualify: - Patients who provide written willing to sign a consent form and who are able and willing to comply with all scheduled study visits and procedures. - Patients ≥ 18 years at the screening visit. - Ocular hypertension or glaucoma controlled with hypotensive treatment - Diagnosis of dry eye Who Should NOT Join This Trial: - Uncontrolled glaucoma with expected changes in antihypertensive treatment in the next 6 months - Changes in topical glaucoma treatment in the last 3 months - Severe dry eye requiring immediate treatment - Previous eye surgery, except cataract surgery more than 12 months ago - Laser procedures less than 6 months ago - Other concomitant ocular pathology: scarring disease of the ocular surface, uveitis, infection in the last 90 days, trauma in the last 90 days - Eyelid disorders - Use of contact lenses - Other topical treatment other than dry eye and glaucoma - Patients with a history of allergy or hypersensitivity to the study medication or any of its excipients - Modifications in systemic immunosuppressive treatment in the last 6 months - History of alcohol or drug abuse - Patients who have received an experimental drug or used an experimental medical device in the 30-day period prior to the screening visit. - Systemic pathology (cardiopulmonary pathology, connective tissue disorders, neurological or psychiatric pathology) or situation of the patient that does not allow examination (such as mental or psychomotor retardation). - Any other disease or condition that, at the discretion of the investigator, could constitute a risk to the participant or interfere with the results of the study. Always talk to your doctor about whether this trial is right for you.